Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biomerica Inc BMRA

Healthcare Medical Devices
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in... see more

Recent & Breaking News (NDAQ:BMRA)

Biomerica Commences Clinical Studies for New Gastroenterology H. Pylori Test

GlobeNewswire September 12, 2017

Biomerica Announces Fiscal Year End 2017 Financial Results; Sales Up 12.7% for the year

GlobeNewswire August 30, 2017

Biomerica Announces Point of Care Product Distribution Agreement with a Multinational Pharmaceutical Company

GlobeNewswire August 16, 2017

Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017

Marketwired May 23, 2017

Biomerica Announces Third Quarter Financial Results, Sales up 13.9% for Nine Months

Marketwired April 17, 2017

Biomerica to present at the 29th Annual ROTH conference on March 13, 2017

Marketwired March 9, 2017

15 Biggest Mid-Day Gainers For Monday

Benzinga.com  December 5, 2016

Biomerica to Present at the 9th Annual LD Micro Main Event

Accesswire November 30, 2016

Exclusive: Newly-Listed Biomerica's CEO Talks IBS, Tech And Patient Care

Benzinga.com  September 6, 2016

Biomerica Announces Third Quarter Financial Results, Sales up 10% for Nine Months

Marketwired April 15, 2016

All Board Members of Biomerica to Purchase Biomerica Common Stock Shares in the Open Market

Marketwired April 7, 2016

Biomerica Announced That Its International Patent Application for IBS Was Reviewed by the ISA and All Claims Have Been Deemed Novel and Non-Obvious

Marketwired March 14, 2016

Biomerica to Present at the ROTH Conference on March 16, 2016

Marketwired March 10, 2016

Biomerica Announces Second Quarter Financial Results

Marketwired January 15, 2016

Biomerica Announces Executive Advisor Appointment for Medical Affairs and Research

Marketwired January 8, 2016

OxySure (OXYS) Launches OxyTrac(TM) to Save Lives & Help Companies Stay Compliant

Accesswire December 10, 2015

Biomerica Reports First Quarter Results; Sales Up Over 24%

Marketwired October 16, 2015

Biomerica Working With FDA on Submission for Its IBS Product

Marketwired September 29, 2015

Biomerica Announces Year End Results

Marketwired September 1, 2015

Biomerica Announces Conference Call Regarding Its Product and Recent Developments in the Irritable Bowel Syndrome (IBS) Market

Marketwired July 6, 2015